Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GeoVax Labs, Inc. - Common Stock (NQ:GOVX)

1.370 -0.030 (-2.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 269,710
Open 1.400
Bid (Size) 1.380 (572)
Ask (Size) 1.400 (17)
Prev. Close 1.400
Today's Range 1.360 - 1.410
52wk Range 1.090 - 11.18
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ATLANTA, GA - March 24, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases,... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory

Performance

YTD
-44.8%
-44.8%
1 Month
-10.5%
-10.5%
3 Month
-39.4%
-39.4%
6 Month
-50.2%
-50.2%
1 Year
-27.9%
-27.9%

More News

Read More
GeoVax to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025
Via NewMediaWire
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health
Via TheNewswire.com
GeoVax to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025
Via TheNewswire.com
GeoVax Labs Inc. (NASDAQ: GOVX) Featured in Coverage of the 37th Annual ROTH Conference
Via Investor Brand Network
Exposures COVID-19
GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK
Via NewMediaWire
GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK
Via TheNewswire.com
GeoVax to Present at the 37th Annual Roth Conference
Via NewMediaWire
Exposures COVID-19
GeoVax to Present at the 37th Annual Roth Conference
Via TheNewswire.com
Exposures COVID-19
Registration is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025
Via TheNewswire.com
Exposures COVID-19
Registration is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025
Via NewMediaWire
Exposures COVID-19
GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy
Via NewMediaWire
Topics Economy
Exposures Supply Chain
GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy
Via TheNewswire.com
Topics Economy
Exposures Supply Chain
GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern
Via NewMediaWire
Topics Death
Exposures Death
GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern
Via TheNewswire.com
Topics Death
Exposures Death
GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness
Via NewMediaWire
Exposures COVID-19
GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness
Via TheNewswire.com
Exposures COVID-19
Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification
Via NewMediaWire
Topics Economy Supply Chain
Exposures Supply Chain
Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification
Via TheNewswire.com
Topics Economy Supply Chain
Exposures Supply Chain
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health
Via NewMediaWire
GeoVax to Present at the Emerging Growth Conference on February 19, 2025
Via NewMediaWire
GeoVax to Present at the Emerging Growth Conference on February 19, 2025
Via TheNewswire.com
GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement Award
Via NewMediaWire
GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement Award
Via TheNewswire.com

Frequently Asked Questions

Is GeoVax Labs, Inc. - Common Stock publicly traded?
Yes, GeoVax Labs, Inc. - Common Stock is publicly traded.
What exchange does GeoVax Labs, Inc. - Common Stock trade on?
GeoVax Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeoVax Labs, Inc. - Common Stock?
The ticker symbol for GeoVax Labs, Inc. - Common Stock is GOVX on the Nasdaq Stock Market
What is the current price of GeoVax Labs, Inc. - Common Stock?
The current price of GeoVax Labs, Inc. - Common Stock is 1.370
When was GeoVax Labs, Inc. - Common Stock last traded?
The last trade of GeoVax Labs, Inc. - Common Stock was at 03/25/25 04:00 PM ET
What is the market capitalization of GeoVax Labs, Inc. - Common Stock?
The market capitalization of GeoVax Labs, Inc. - Common Stock is 2.98M
How many shares of GeoVax Labs, Inc. - Common Stock are outstanding?
GeoVax Labs, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.